Concord Biotech Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Total Qtr Revenue cr | 341.43 | ||||
| Other Income Qtr Cr | 15.35 | ||||
| Operating Revenues Qtr | 326.08 | ||||
Loading chart... | |||||
Operating Expenses Qtr | 207.55 | ||||
Operating Profit Qtr | 118.53 | ||||
EBITDA Qtr Cr | 133.88 | ||||
Depreciation Qtr | 19.54 | ||||
Net Profit Qtr | 88.79 | ||||
Basic EPS Qtr | 8.46 | ||||
